CN101422579B - 一种治疗口腔溃疡的中药制剂 - Google Patents
一种治疗口腔溃疡的中药制剂 Download PDFInfo
- Publication number
- CN101422579B CN101422579B CN2008102381267A CN200810238126A CN101422579B CN 101422579 B CN101422579 B CN 101422579B CN 2008102381267 A CN2008102381267 A CN 2008102381267A CN 200810238126 A CN200810238126 A CN 200810238126A CN 101422579 B CN101422579 B CN 101422579B
- Authority
- CN
- China
- Prior art keywords
- parts
- portions
- chinese medicine
- radix
- medicine preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 101
- 208000002399 aphthous stomatitis Diseases 0.000 title claims abstract description 43
- 238000002360 preparation method Methods 0.000 title claims abstract description 41
- 208000007117 Oral Ulcer Diseases 0.000 title claims abstract description 33
- 239000010231 banlangen Substances 0.000 claims abstract description 15
- 235000000177 Indigofera tinctoria Nutrition 0.000 claims abstract description 3
- 241001078983 Tetradium ruticarpum Species 0.000 claims abstract description 3
- 229940097275 indigo Drugs 0.000 claims abstract description 3
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 claims abstract description 3
- 238000011282 treatment Methods 0.000 claims description 36
- 239000000843 powder Substances 0.000 claims description 20
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims description 19
- 235000006226 Areca catechu Nutrition 0.000 claims description 18
- 241000756943 Codonopsis Species 0.000 claims description 17
- 241000628997 Flos Species 0.000 claims description 17
- 244000080767 Areca catechu Species 0.000 claims description 16
- 239000000865 liniment Substances 0.000 claims description 12
- 229940040145 liniment Drugs 0.000 claims description 12
- 239000002994 raw material Substances 0.000 claims description 12
- 230000003203 everyday effect Effects 0.000 claims description 9
- 241000245240 Lonicera Species 0.000 claims description 8
- 241000545442 Radix Species 0.000 claims description 8
- 239000002552 dosage form Substances 0.000 claims description 4
- 208000002193 Pain Diseases 0.000 abstract description 30
- 230000036407 pain Effects 0.000 abstract description 30
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 abstract description 7
- 239000000463 material Substances 0.000 abstract description 7
- 230000008901 benefit Effects 0.000 abstract description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 abstract 1
- 235000017491 Bambusa tulda Nutrition 0.000 abstract 1
- 241001313857 Bletilla striata Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 206010067482 No adverse event Diseases 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 241000972672 Phellodendron Species 0.000 abstract 1
- 244000082204 Phyllostachys viridis Species 0.000 abstract 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 abstract 1
- 241000381592 Senegalia polyacantha Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 239000011425 bamboo Substances 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
- 210000000214 mouth Anatomy 0.000 description 25
- 208000025865 Ulcer Diseases 0.000 description 24
- 239000008280 blood Substances 0.000 description 23
- 210000004369 blood Anatomy 0.000 description 23
- 230000000694 effects Effects 0.000 description 23
- 231100000397 ulcer Toxicity 0.000 description 23
- 230000001737 promoting effect Effects 0.000 description 20
- 201000010099 disease Diseases 0.000 description 19
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 19
- 210000000952 spleen Anatomy 0.000 description 19
- 239000000203 mixture Substances 0.000 description 16
- 230000007812 deficiency Effects 0.000 description 13
- 210000002216 heart Anatomy 0.000 description 13
- 231100000614 poison Toxicity 0.000 description 13
- 239000009636 Huang Qi Substances 0.000 description 11
- 235000009508 confectionery Nutrition 0.000 description 11
- 210000004072 lung Anatomy 0.000 description 11
- 210000002784 stomach Anatomy 0.000 description 11
- 230000035876 healing Effects 0.000 description 9
- 239000003440 toxic substance Substances 0.000 description 9
- 238000002156 mixing Methods 0.000 description 8
- 230000001717 pathogenic effect Effects 0.000 description 8
- 206010007247 Carbuncle Diseases 0.000 description 7
- 210000001124 body fluid Anatomy 0.000 description 7
- 239000010839 body fluid Substances 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 238000012856 packing Methods 0.000 description 7
- 239000003826 tablet Substances 0.000 description 7
- 229920000742 Cotton Polymers 0.000 description 6
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 5
- 206010040943 Skin Ulcer Diseases 0.000 description 5
- 208000033809 Suppuration Diseases 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 230000003628 erosive effect Effects 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 238000005469 granulation Methods 0.000 description 5
- 230000003179 granulation Effects 0.000 description 5
- 208000013403 hyperactivity Diseases 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- 229940023488 pill Drugs 0.000 description 5
- 239000006187 pill Substances 0.000 description 5
- 231100000019 skin ulcer Toxicity 0.000 description 5
- 206010004542 Bezoar Diseases 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 230000000202 analgesic effect Effects 0.000 description 4
- 230000000840 anti-viral effect Effects 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 210000002200 mouth mucosa Anatomy 0.000 description 4
- 231100000252 nontoxic Toxicity 0.000 description 4
- 230000003000 nontoxic effect Effects 0.000 description 4
- 239000002574 poison Substances 0.000 description 4
- 206010040872 skin infection Diseases 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 230000017423 tissue regeneration Effects 0.000 description 4
- 239000003860 topical agent Substances 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 210000004877 mucosa Anatomy 0.000 description 3
- 210000003800 pharynx Anatomy 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- BAHMQESJBKGPTE-UHFFFAOYSA-N 1,5,8-trimethyl-3a,4-dihydroazuleno[6,5-b]furan-2,6-dione Chemical compound C1C2OC(=O)C(C)=C2C=C2C(C)=CC(=O)C2=C1C BAHMQESJBKGPTE-UHFFFAOYSA-N 0.000 description 2
- 244000235603 Acacia catechu Species 0.000 description 2
- 208000000412 Avitaminosis Diseases 0.000 description 2
- 208000003322 Coinfection Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010020565 Hyperaemia Diseases 0.000 description 2
- 206010021135 Hypovitaminosis Diseases 0.000 description 2
- 208000005647 Mumps Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 240000005001 Paeonia suffruticosa Species 0.000 description 2
- 235000003889 Paeonia suffruticosa Nutrition 0.000 description 2
- 240000005373 Panax quinquefolius Species 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 206010043458 Thirst Diseases 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000002605 anti-dotal effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 229940068682 chewable tablet Drugs 0.000 description 2
- 239000007910 chewable tablet Substances 0.000 description 2
- 229940112822 chewing gum Drugs 0.000 description 2
- 235000015218 chewing gum Nutrition 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 208000010805 mumps infectious disease Diseases 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 230000009278 visceral effect Effects 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- 208000030401 vitamin deficiency disease Diseases 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- XWMMEBCFHUKHEX-MRTCRTFGSA-N (+)-Taraxasterol Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC[C@]1(C)[C@@H]2CC[C@H]2[C@@H]3[C@H](C)C(=C)CC[C@]3(C)CC[C@]21C XWMMEBCFHUKHEX-MRTCRTFGSA-N 0.000 description 1
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- QMKPCZNFLUQTJZ-UHFFFAOYSA-N (4aR)-10c-Hydroxy-1t.2c.4ar.6at.6bc.9.9.12ac-octamethyl-(8atH.12btH.14acH.14btH)-docosahydro-picen Natural products CC1CCC2(C)CCC3(C)C(CCC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C QMKPCZNFLUQTJZ-UHFFFAOYSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- LFFQVHXIFJLJSP-IZLXSDGUSA-N 6,6'-dimethoxy-2,2'-dimethyl-oxyacanthan-7 Chemical compound C([C@@H]1N(C)CCC=2C=C(C(=C(OC3=C(OC)C=C4CCN(C)[C@@H](C4=C3)CC=3C=C(C(=CC=3)O)O3)C=21)O)OC)C1=CC=C3C=C1 LFFQVHXIFJLJSP-IZLXSDGUSA-N 0.000 description 1
- 206010002153 Anal fissure Diseases 0.000 description 1
- 241001419719 Anisodus carniolicoides Species 0.000 description 1
- 208000016583 Anus disease Diseases 0.000 description 1
- IRLNKOAURQPXIQ-WWWUCTDISA-N Apiopaeonoside Natural products O=C(C)c1c(O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO[C@H]3[C@H](O)[C@@](O)(CO)CO3)O2)cc(OC)cc1 IRLNKOAURQPXIQ-WWWUCTDISA-N 0.000 description 1
- LFFQVHXIFJLJSP-WUFINQPMSA-N Aromoline Natural products C([C@H]1N(C)CCC=2C=C(C(=C(OC3=C(OC)C=C4CCN(C)[C@H](C4=C3)CC=3C=C(C(=CC=3)O)O3)C=21)O)OC)C1=CC=C3C=C1 LFFQVHXIFJLJSP-WUFINQPMSA-N 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- LFFQVHXIFJLJSP-UHFFFAOYSA-N Candicusine Natural products O1C(C(=CC=2)O)=CC=2CC(C2=C3)N(C)CCC2=CC(OC)=C3OC(C=23)=C(O)C(OC)=CC=2CCN(C)C3CC2=CC=C1C=C2 LFFQVHXIFJLJSP-UHFFFAOYSA-N 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 241000905957 Channa melasoma Species 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010013700 Drug hypersensitivity Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 208000009531 Fissure in Ano Diseases 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028034 Mouth ulceration Diseases 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 208000025157 Oral disease Diseases 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 1
- IDZZECHGWAZTIB-NYBIBFQCSA-N Paeonolide Chemical compound COC1=CC=C(C(C)=O)C(O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]3[C@@H]([C@@H](O)[C@@H](O)CO3)O)O2)O)=C1 IDZZECHGWAZTIB-NYBIBFQCSA-N 0.000 description 1
- IDZZECHGWAZTIB-WPQJODJHSA-N Paeonolide Natural products O=C(C)c1c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]3[C@@H](O)[C@H](O)[C@@H](O)CO3)O2)cc(OC)cc1 IDZZECHGWAZTIB-WPQJODJHSA-N 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010042566 Superinfection Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 208000016150 acute pharyngitis Diseases 0.000 description 1
- IDZZECHGWAZTIB-UHFFFAOYSA-N affinoside Natural products COC1=CC=C(C(C)=O)C(OC2C(C(O)C(O)C(COC3C(C(O)C(O)CO3)O)O2)O)=C1 IDZZECHGWAZTIB-UHFFFAOYSA-N 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- -1 boronic acid compound Chemical class 0.000 description 1
- 210000005178 buccal mucosa Anatomy 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 238000001354 calcination Methods 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 201000005311 drug allergy Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- XTLWNMXYCHABQH-UHFFFAOYSA-N germanicol Natural products CC1(C)CCC2(C)CCC3(C)C(CCC4(C)C5(C)CCC(O)C(C)(C)C5CCC34C)C2=C1 XTLWNMXYCHABQH-UHFFFAOYSA-N 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 206010018388 glossodynia Diseases 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 150000002333 glycines Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000003450 growing effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 229920002414 procyanidin Polymers 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- NGFFRJBGMSPDMS-UHFFFAOYSA-N psi-Taraxasterol Natural products CC12CCC(O)C(C)(C)C1CCC1(C)C2CCC2C3C(C)C(C)=CCC3(C)CCC21C NGFFRJBGMSPDMS-UHFFFAOYSA-N 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 239000010201 sheng-ji-san Substances 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- HUTYZQWCTWWXND-NCTFTGAASA-N taraxasterol Natural products C[C@H]1[C@H]2C3=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)C[C@H](O)[C@@]2(C)CCC1=C HUTYZQWCTWWXND-NCTFTGAASA-N 0.000 description 1
- GGGUGZHBAOMSFJ-GADYQYKKSA-N taraxerol Chemical compound CC([C@@H]1CC2)(C)[C@@H](O)CC[C@]1(C)[C@@H]1[C@]2(C)C2=CC[C@@]3(C)CCC(C)(C)C[C@H]3[C@]2(C)CC1 GGGUGZHBAOMSFJ-GADYQYKKSA-N 0.000 description 1
- HYTFUKZLSYXRDX-UHFFFAOYSA-N taraxerol Natural products CC1CCCC2C3(C)CCC4(C)C5CC(C)(C)CCC5(C)C=CC4(C)C3C(O)CC12C HYTFUKZLSYXRDX-UHFFFAOYSA-N 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000005182 tip of the tongue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗口腔溃疡的中药制剂,由内服药物和外敷药物组成,所述内服药物中各种原料的重量的份数比为:黄连10~20份,竹叶10~20份,黄柏10~20份,蒲公英10~20份,黄芪10~20份,党参10~20份,板蓝根10~20份,金银花10~20份,儿茶10~20份,当归10~20份,生地黄10~20份;所述外敷药物中各种原料的重量份数比为:青黛10~20份,冰片10~20份,丹皮10~20份,白芨10~20份,吴茱萸10~20份。本发明中药制剂通过内服与外部局部涂抹,使药力直达病灶,减轻病患痛苦,内外兼治,患者无不良反应。本发明中药制剂制作方法简单,所需设备少,操作容易,能够取得良好经济效益。
Description
技术领域
本发明涉及含有来源于植物、动物或矿物原料的医用配制品,特别涉及一种治疗口腔溃疡的中药制剂。
背景技术
口腔溃疡病是临床上的常见的口腔疾病、多发病,也是常见的溃疡性损害,可单发或多发于口腔粘膜的任何部位。具有周期性及烧灼性疼痛的特点,发病年龄以青壮年为多,而且女性多于男性。发作时,常因疼痛而影响进食和睡眠,一旦在局部形成溃疡后可继发感染,造成溃疡局部组织炎症和坏死,使病程延长,增加患者的痛苦,属口腔科疑难杂症之一。口腔溃疡属祖国医学口疮、口糜、口疳等范畴,临床以口腔粘膜发红、溃烂为特征。现代医学认为其发病机制可能与病毒感染、代谢障碍、维生素缺乏、内分泌异常、消化功能紊乱及精神因素有关。祖国医学认为本病虽发于口腔局部,但却与全身脏腑功能失调密切相关,历代医家多从脾胃积热、脾胃气虚、心肝火旺、脾肾虚衰、肝肾阴虚等论治。《圣济总录》曰:“心脾有热,气冲上焦重发口舌作疮也”。口为胃之窍,舌为心之苗,脾脉通于舌,故口腔溃疡为心脾热盛而发。中医理论认为病虽生于口,实与脏腑经络密切相关。缘脾开窍于口,心开窍于舌,肾脉连咽系舌本,两颊及齿龈属胃与大肠经。由于饮食不当、劳倦、情志困扰等因素所伤,造成脏腑功能失调,心脾蕴热、胃火炽盛;或气阴亏虚,阴虚火旺;或脾肾阳虚,无根之火上浮,熏蒸口舌,均可导致本病的发生。
现代医学认为其发病病因较为复杂,可因药物过敏、血液病、维生素缺乏、服用化疗药物、肿瘤晚期或全身疾病等因素所致,目前尚无较理想的药物,治疗上首选抗抗生素、维生素、止痛片等,用于抗菌消炎、止痛、增加维生素等对症治疗。现在患者发病后一般使用华素片、锡类散、冰硼散等西药治疗,这类药物虽然有一定的疗效,但是很难完全治愈,容易复发。甚至有些患者因服用广谱抗生素,原发溃疡未愈,又造成二重感染,缠绵难愈。这些药物只能对口腔溃疡进行局部缓解或治疗,都无法解决顽固性口腔溃疡病容易反复发作的问题。目前治疗这种疾病的外用药中,西药,如盐酸洗必泰、复方硼酸溶液、溶菌酶等,多以防止继发感染,减轻疼痛为目的,其缺点是愈后较易复发,且有一定的毒副作用。内服具有清热养阴,收敛生肌功效的中药包括传统牛黄解毒丸、牛黄上清丸等,缺点则是止痛的效果差,疗效不佳,没有特殊针对性,而且用药时间长,剂量大,难以达到满意的效果。另外外用的中药复方制剂很多,有片剂、散剂、含漱剂、甘油剂、软膏剂,传统中成药冰硼散、养阴生肌散等等,但这些剂型易被唾液稀释,难以直达病灶或局部粘附性差而影响疗效。
发明内容
本发明所要解决的技术问题在于,提供一种治疗口腔溃疡的中药制剂。本发明是一种纯中药制剂,利用几味常见的中药特性,内外兼治,养阴生津,清虚火,调理胃肾阴虚,虚火上炎,滋阴清热,凉血消肿,泻肺热,使机体阴阳平衡,达到清利咽喉,养阴生津,解毒泻火标本共治的效果;而且配方科学,用药量较小、口感好,价格低廉,使用方便,能够直达病灶,有效治疗口腔溃疡。可广泛用于男女老幼,体弱患者,且无毒性,不易复发,安全性较好。
为解决上述技术问题,本发明提供一种治疗口腔溃疡的纯中药制剂,由内服药物和外敷药物组成,所述内服药物中各种原料的重量份数比为:黄连10~20份,竹叶10~20份,黄柏10~20份,蒲公英10~20份,黄芪10~20份,党参10~20份,板蓝根10~20份,金银花10~20份,儿茶10~20份,当归10~20份,生地黄10~20份;
所述外敷药物中,各种原料的重量份数比为:青黛10~20份,冰片10~20份,丹皮10~20份,白芨10~20份,吴茱萸10~20份。
所述治疗口腔溃疡的中药制剂,内服药物中各种原料的重量份数比优选为:黄连10~15份,竹叶10~15份,黄柏10~15份,蒲公英10~15份,黄芪10~15份,党参10~15份,板蓝根10~15份,金银花15~20份,儿茶15~20份,当归15~20份,生地黄15~20份。
所述治疗口腔溃疡的中药制剂,内服药物中各种原料的重量份数比还可优选为:黄连10~15份,竹叶10~15份,黄柏10~15份,蒲公英15~20份,黄芪10~15份,党参10~15份,板蓝根10~20份,金银花10~20份,儿茶10~20份,当归10~20份,生地黄10~20份。
所述治疗口腔溃疡的中药制剂,内服药物中各种原料的重量份数比也可优选为:黄连10~20份,竹叶10~20份,黄柏10~20份,蒲公英10~20份,黄芪15~20份,党参10~20份,板蓝根10~20份,金银花10~15份,儿茶10~15份,当归10~20份,生地黄10~15份。
所述治疗口腔溃疡的中药制剂的外敷药物,使用时可以将各成分研碎混合,成为细末状,用棉签将细末涂抹于患处。每日三次,每5天为一个疗程。
所述治疗口腔溃疡的中药制剂的内服药物,在使用时可以煎汤剂服用,每日1剂,水煎分两次服,每5天为一疗程。
所述治疗口腔溃疡的中药制剂的内服药物使用时,剂型为片剂或散剂服用时,可以一天三次,每次一片,每5天为一疗程。
所述治疗口腔溃疡的中药制剂,所述内服药剂可以为:蜜炼丸剂、水合丸剂、胶囊、口服液、颗粒剂、胶剂、糖浆剂,或添加到食品中制成口香糖或咀嚼片。
所述中药制剂散剂的制备方法可以包括:
粉碎的步骤:将所述原料按配比混合,投入粉碎机粉碎成细粉,粒度为80~110目;
混合的步骤:将上述步骤所得细粉投入混合搅拌机充分混匀;
包装的步骤:将混匀后的细粉用小瓶或包装盒分装,每2~5克为一瓶或一盒分装。
所述治疗口腔溃疡的中药制剂,在使用时,可以内服药物与外敷药物组合使用,先服用内服药物汤剂,片剂或散剂,10min后使用外敷药物涂抹。
本发明与现有技术比较,具有药物原料价格低廉,都是些常见中药,药剂易于制作,成本低廉;并且配方科学,标本兼治,能有效调理人体机制,以及改善血液循环;外用时直达病灶,使用方便,治愈时间短,疗效好,能有效缓解疼痛,且不易复发,能够创造良好的社会价值与经济利益。
具体实施方式
祖国医学认为口腔溃疡发病主要与“火”因素有关,因而中医认为溃疡由实火和虚火引发。实火多由过食膏粱厚味、醇酒灸或外邪引动心肺、脾胃之火上炎;虚火则多因素体阴虚或思虑太过,耗伤真阴,心肾不交,阴虚火旺。总之,中医认为口疮与情志因素有一定关系,尤其与心火有关,本中药制剂配方针对人体内所生心火,选用具有清热解毒去心火功效的中药,科学配比,能消除或减轻病痛,促进溃疡愈合,防止复发,有良好的清热解毒,消散郁火,凉血消肿,生肌收敛之功能,对各症型都有效,有较好的止痛和促进愈合作用。
本发明采用具有泻心火,除脾胃中湿热的黄连之苦,以导泻心下之虚热,《药性解》注:黄连,味苦,性寒,无毒,入心经。主心火炎,目疾暴发,疮疡红肿,肠红下痢,痞满泄泻,小儿疳热,消中口疮,惊悸烦躁,天行热疾。黄连味苦泻心,治心火诸病不可缺。
竹叶味甘淡,气平微凉,用于心火炽盛引起的口舌生疮、尿少而赤。清热除烦,生津利尿,治热病烦渴,用于热病后余热未尽之燥热心烦口糜舌疮。《本草正》云:退虚热烦躁不眠,止烦渴,生津液,利小水,解喉痹,并小儿风热惊痫。因其味甘气淡是口舌生疮治疗之佳品。
黄柏主治清热燥湿,泻火除蒸,解毒疗疮。《中国药典》介绍黄柏清热燥湿之力,与黄芩、黄连相似,但以除下焦之湿热为佳,是治湿热疮疡的良药。
蒲公英是一味常用的中药,其药用价值早已载入各种医书。它全草入药,含蒲公英甾醇、蒲公英赛醇、蒲公英苦素、咖啡酸、胆碱、菊糖等成分。性平味甘微苦。可清热解毒,消肿散结。《本草纲目》记载:“解食毒,散滞气,清热毒,化食毒,消恶肿、结核、疔肿。”。蒲公英昧甘平,其性无毒。当是入肝入胃,解热凉血之要药。
黄芪以补虚为主,能补气固表,利尿托毒,排脓,敛疮生肌。用于气血不足、疮疡内陷、脓成不溃或久溃不敛者。黄芪具有很好的托毒生肌的功能,即久不愈合的脓肿化脓生肌。现代医学研究表明,黄芪内含而多种抗菌有效成分,而且能增强机体的免疫功能,因此还能用于预防某些传染病的发生。《本草逢原》载:“黄芪能补五脏诸虚,治脉弦自汗,泻阴火,去肺热,无汗则发,有汗则止。”是增进抵抗力和防御疾病的良药。
党参性平,味甘、微酸。归脾、肺经。补中益气,健脾益肺。用于脾肺虚弱,气短心悸,食少便溏,虚喘咳嗽,内热消渴。《本草正义》载:党参力能补脾养胃,润肺生津,腱运中气,本与人参不甚相远。其尤可贵者,则健脾运而不燥,滋胃阴而不湿,润肺而不犯寒凉,养血而不偏滋腻,鼓舞清阳,振动中气,而无刚燥之弊。黄芪补气、既能升补脾气,又能益肺固表。党参补气,只能健脾补气,无固表之力,但党参还能益气生津,黄芪则无生津之效,黄芪兼能利水,党参无利水作用。这两味药合用最能补中益气,提高抵抗力。
板蓝根在临床上清热凉血、抗病毒抗菌作用明显,用量大,堪称中成药之最。研究结果表明,板蓝根具有显著的清除体内能引起体温升高的热原作用。《分类草药性》载:“解诸毒恶疮,散毒去火。”并且价格低廉,毒副作用小,是广受欢迎的清热解毒的良药。
丹皮性寒,味苦、辛。具有清热凉血,活血行瘀。用于温毒发斑、痈肿疮毒。《本草纲目》载:“治血中伏火,除烦热。”此药含牡丹酸、牡丹酸甙、牡丹酚原甙、芍药甙、挥发油及植物甾醇等,丹皮酚及糖甙成分均有抗炎作用。丹皮酚有镇静、降温、解热、镇痛、解痉等中枢抑制作用。是非常好的镇痛;清热,化淤的外用良药。
吴茱萸性热,味辛、苦,散寒止痛,入肝、脾、胃、大肠、肾经。外用具有比较明显的止痛与治疗效果。《雷公炮制药性解》:温中,止痛,理气,燥湿。是治疗口腔溃疡外用的良药。
《本草纲目》载“金银花,善于化毒,故治痈疽、肿毒、疮癣......”。自古以来,金银花常用于清热解毒,治疗温病发热,热毒血痢,痈疡等症。现代药理研究表明,金银花具有抑菌、抗病毒、抗炎、解热、调节免疫等作用中医认为,金银花性寒、味甘、气平,具有清热解毒之功效,可以治疗热毒肿疡、痈疽疔疮等症。且兼有宣散作用。金银花清热解毒作用颇强,在外科中为常用之品,一般用于有红肿热痛的疮痈肿毒,
儿茶选自《古今医方集成》之传统的内服外用均可的七厘散,其味苦、涩,性凉,具有清热化痰、活血疗伤、生肌止痛、收湿敛疮的功效。临床用于外伤瘀肿、疮痈、湿疮、牙疳等,本制剂主要取其清热收湿、活血止痛、生肌敛疮之功效。现代药理研究发现儿茶含有儿茶鞣酸、儿茶素、表儿茶素、儿茶红、槲皮素、树胶等。儿茶水浸剂溶液还有抗病毒、杀真菌、抗癌及预防胃溃疡的作用。儿茶煎剂对金黄色葡萄球菌、变形杆菌、福氏痢疾杆菌及伤寒杆菌均有抑制作用,对于常见致病性皮肤真菌也有抑制作用。儿茶苦、涩,微寒。归肺经。功能收湿生肌敛疮。多用于溃疡不敛,湿疹,口疮的治疗。
青黛具有清热,凉血,解毒的功效,且性甘,平,无毒,入肝、肺、胃经。清热解毒,凉血,定惊,用于温毒发斑,血热吐衄,胸痛咳血,口疮,痄腮,据《要药分剂》载:除热解毒,兼能凉血。《岭南采药录》注:可涂疮及痄腮。《雷公炮制药性解》载:“入肝,脾二经。”是治疗口腔溃疡内用外用兼可的良药。
当归,其味甘而重,故专能补血,其气轻而辛,故又能行血,补中有动,行中有补,诚血中之气药,亦血中之圣药。大约佐之以补则补,故能养营养血,补气生精,安五脏,强形体,益神志,凡有形虚损之病,无所不宜。佐之以攻则通,故能祛痛通便,利筋骨,治拘挛、瘫痪、燥、涩等证。营虚而表不解者,佐以柴、葛、麻、桂等剂,大能散表卫热,而表不敛者,佐以大黄之类,又能固表。惟其气辛而动,故欲其静者当避之,性滑善行,大便不固者当避之。凡阴中火盛者,当归能动血,亦非所宜,阴中阳虚者,当归能养血,乃不可少。
白芨味苦、甘、涩,性寒,归肺、胃。肝经。有收敛止血,消肿生肌之功,用于内外出血诸证及痈肿、烫伤、手足皲裂、肛裂等。《神农本草经》:“主痈肿、恶疮、败疽,伤阴死肌,胃中邪气”白芨功在止血疗伤,故寓意“医治创伤”,是一味外科良药。
生地黄味甘、苦,性寒.入心、肝、肾经,具有清热生津滋阴养血之功效。《本经》载:“味甘;寒。”《别录注》“苦,无毒。”入心、肝、脾、肺四经,是一味滋阴养血活血之良药。
冰片用于目赤肿痛,喉痹口疮。冰片苦寒,有清热止痛、消肿之功,为五官科常用药。治疗咽喉肿痛、口舌生疮,常与硼砂、朱砂、玄明粉共研细末,吹敷患处,如冰硼散。治疗风热喉痹,用于疮疡肿痛,溃后不敛。本品亦有清热解毒、防腐生肌作用。是外用治疗口腔溃疡的良药佳品。
本发明治疗口腔溃疡的中药制剂的剂型可以为:蜜炼丸剂、水合丸剂、胶囊、口服液、颗粒剂、胶剂、糖浆剂,或添加到食品中制成口香糖或咀嚼片。
本发明中药制剂散剂的制备方法包括:
将所述原料按配比混合,投入粉碎机粉碎成细粉,粒度为80~110目;
将上述步骤所得细粉投入混合搅拌机充分混匀;
将混匀后的细粉用小瓶或包装盒分装,每2~5克为一瓶或一盒分装。
本发明中药制剂在使用时,内服药物与外敷药物组合使用,先内服药物汤剂或散剂,10min后使用外敷药物涂抹患处。
所述中药制剂的外敷药物,使用时应将各成分研碎混合,成为细末状,用棉签将细末涂抹于患处即可。
实施例1:张某,女18岁,口腔反复发作溃疡一年。经检查发现左侧颊粘膜,上唇粘膜有4个溃疡面,表面呈灰白色,有黄液渗出,周围粘膜充血呈红晕环,灼烧痛明显,进食时尤其接触刺激性食物疼痛更为严重。便秘,舍质红,苔黄。症属心脾积热。用下列处方:
内服:黄连10g,竹叶15g,黄柏10g,蒲公英10g,黄芪10g,党参10g,板蓝根10g,金银花20g,儿茶10g,当归20g,生地黄10g;
外敷:冰片15g,丹皮10g,吴茱萸10g,白芨20g,青黛10g,应将各成分研碎混合,成为细末状,用棉签将散剂涂抹于患处。
内服药物作汤剂,每天1剂,水煎分两次服。外用药剂每日涂抹三次,次日疼痛明显减轻,溃疡面缩小。3天后溃疡面治愈。经访一年未复发。
实施例2:金某,女35岁,教师,自述患口腔溃疡反复发作三年余,几乎每月发作两次,曾服维生素B2片,阿莫灵胶囊,黄连上清丸以及外喷冰硼伞和西瓜霜等均未治愈。近两个月来发作频繁,此起彼伏。就诊时见舌缘,舌尖及下唇内侧有多处溃疡,状如黄豆大小,上有白膜覆盖,周围有红肿,讲话,吞咽均痛。症属应是心脾积热,血淤不化,郁火上炎所致。用下列处方:
内服:黄连10g,竹叶10g,黄柏15g,蒲公英20g,黄芪10g,党参10g,板蓝根20g,金银花20g,儿茶10g,当归20g,生地黄10g;
外敷:冰片15g,丹皮10g,吴茱萸15g,白芨20g,青黛15g,应将各成分研碎混合,成为细末状,用棉签将散剂涂抹于患处。。
内服药物作为片剂使用,一天三次,外用药剂每日涂抹三次,次日疼痛明显减轻,溃疡面缩小。4天后溃疡愈合。随访一年未复发。
实施例3:张某,男,42岁,自诉反复口烂2年,曾口服地塞米松、维生素、外贴口腔溃疡膜,治疗用药时有效,停药1周后又出现口烂,接触刺激性食物疼痛,进食受限,近来晚上睡眠不好,多汗,腰膝酸软,便秘。查体:口唇、颊黏膜有多个散在分布大小不等溃疡面,中间凹陷微黄,周围充血呈红晕状,舌质红苔薄黄,脉细数。诊断为复发性口腔溃疡,证属阴虚火旺。用下列处方:
内服:黄连15g,竹叶10g,黄柏10g,蒲公英20g,黄芪10g,党参15g,板蓝根20g,金银花20g,儿茶15g,当归10g,生地黄20g;
外敷:冰片20g,丹皮10g,吴茱萸20g,白芨15g,青黛10g,应将各成分研碎混合,成为细末状,用棉签将散剂涂抹于患处。
内服药剂为散剂使用,每日三次,外用药剂每日涂抹三次,次日感觉疼痛减轻,3天后疼痛消失,溃疡面愈合。跟踪回访1年未复发。
实施例4:佟某,女,38岁。患者口腔溃烂,咽、舌燥痛,反复发作6年,加重1月。就诊时口腔两侧黏膜呈现弥漫性溃烂,舌内溃疡成片,活动不灵活,上下唇亦溃烂,张口、吞咽均觉困难,大便燥结,伴胃脘胀痛,遇寒尤甚,口干苦,舌质红,苔厚腻,脉弦而数。曾服维生素B2、多种维生素及中成药牛黄解毒片、牛黄清胃丸等均未效,且大便越干燥,脘腹胀痛、口干加重。此乃湿热蕴化,郁结脾胃,中焦虚寒郁久,郁火上炎所致。治宜温胃化湿,清泻郁火。用下列处方:
内服:黄连15g,竹叶15g,黄柏10g,蒲公英20g,黄芪10g,党参15g,板蓝根20g,金银花20g,儿茶15g,当归20g,生地黄10g;
外敷:冰片20g,丹皮10g,吴茱萸20g,白芨20g,青黛15g,应将各成分研碎混合,成为细末状,用棉签将散剂涂抹于患处。
内服药物为片剂,外用药剂每日涂抹三次。次日感觉疼痛明显减轻,4天后疼痛消失,5天后溃疡面愈合。随访2年以上未见复发。
在52例口腔溃疡患者中,男性22例,女性30例;发病年龄16岁至65岁,其中以22岁到50岁最为常见,约占78%,病程1年以上27例,2年以上12例,三年以上7例,五年以上6例。治疗结果治愈42例,有效8例,无效2例,总有效率96.2%。本发明中药制剂一般1至2天生效,用药1天后疼痛明显减轻,用药5天后溃疡基本痊愈。停用后一般无复发。
Claims (7)
1.一种治疗口腔溃疡的中药制剂,其特征在于,由内服药物和外敷药物组成,
所述内服药物中各种原料的重量份数比为:黄连10~20份,竹叶10~20份,黄柏10~20份,蒲公英10~20份,黄芪10~20份,党参10~20份,板蓝根10~20份,金银花10~20份,儿茶10~20份,当归10~20份,生地黄10~20份;
所述外敷药物中,各种原料的重量份数比为:青黛10~20份,冰片10~20份,丹皮10~20份,白芨10~20份,吴茱萸10~20份。
2.根据权利要求1所述治疗口腔溃疡的中药制剂,其特征在于,所述内服药物中各种原料的重量份数比为:黄连10~15份,竹叶10~15份,黄柏10~15份,蒲公英10~15份,黄芪10~15份,党参10~15份,板蓝根10~15份,金银花15~20份,儿茶15~20份,当归15~20份,生地黄15~20份。
3.根据权利要求1所述治疗口腔溃疡的中药制剂,其特征在于,所述内服药物中各种原料的重量份数比为:黄连10~15份,竹叶10~15份,黄柏10~15份,蒲公英15~20份,黄芪10~15份,党参10~15份,板蓝根10~20份,金银花10~20份,儿茶10~20份,当归10~20份,生地黄10~20份。
4.根据权利要求1所述治疗口腔溃疡的中药制剂,其特征在于,所述内服药物中各种原料的重量份数比为:黄连10~20份,竹叶10~20份,黄柏10~20份,蒲公英10~20份,黄芪15~20份,党参10~20份,板蓝根10~20份,金银花10~15份,儿茶10~15份,当归10~20份,生地黄10~15份。
5.根据权利要求1~4中任一项所述治疗口腔溃疡的中药制剂,其特征在于,所述中药制剂的内服药物,在使用时煎汤剂服用,每日1剂,水煎分两次服,每5天为一疗程。
6.根据权利要求1~4中任一项所述治疗口腔溃疡的中药制剂,其特征在于,所述中药制剂的内服药物使用时,剂型为片剂或散剂服用时,一天三次,每次一片,每5天为一疗程。
7.根据权利要求1~4中任一项所述治疗口腔溃疡的中药制剂,其特征在于,使用所述中药制剂时,内服药物与外敷药物组合使用,先服用内服药物汤剂,片剂或散剂,10min后使用外敷药物涂抹。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008102381267A CN101422579B (zh) | 2008-12-09 | 2008-12-09 | 一种治疗口腔溃疡的中药制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008102381267A CN101422579B (zh) | 2008-12-09 | 2008-12-09 | 一种治疗口腔溃疡的中药制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101422579A CN101422579A (zh) | 2009-05-06 |
CN101422579B true CN101422579B (zh) | 2011-06-15 |
Family
ID=40613610
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008102381267A Expired - Fee Related CN101422579B (zh) | 2008-12-09 | 2008-12-09 | 一种治疗口腔溃疡的中药制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101422579B (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101966328B (zh) * | 2010-09-28 | 2012-05-30 | 刘瑞英 | 治疗鹅口疮的外用中药 |
CN102600365B (zh) * | 2012-03-31 | 2013-06-05 | 孔德红 | 一种治疗口腔溃疡的药剂 |
CN102688462B (zh) * | 2012-05-08 | 2014-04-09 | 安徽智远生物科技有限公司 | 一种治疗口腔溃疡的中药及其制备方法 |
CN103877223B (zh) * | 2014-03-03 | 2015-09-30 | 青岛市市立医院 | 一种治疗口腔念珠菌病的药物组合物及其应用 |
CN104027413A (zh) * | 2014-06-18 | 2014-09-10 | 潘井生 | 一种治疗口腔溃疡的中药组合物 |
CN104304629A (zh) * | 2014-09-18 | 2015-01-28 | 中山市品汇创新专利技术开发有限公司 | 一种中药香型口香糖 |
CN104288578B (zh) * | 2014-10-29 | 2015-08-05 | 青岛市中心医院 | 一种治疗口腔溃疡的药物组合物 |
CN105166305A (zh) * | 2015-08-27 | 2015-12-23 | 济南舜祥医药科技有限公司 | 一种保健口香糖及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1317328A (zh) * | 2000-04-13 | 2001-10-17 | 崔北双 | 一种口腔溃疡药 |
CN1857635A (zh) * | 2006-03-29 | 2006-11-08 | 王忠英 | 一种治疗口臭的漱口内服中药制备方法 |
CN1895585A (zh) * | 2006-06-28 | 2007-01-17 | 陈江 | 口气清新饮料 |
CN101066399A (zh) * | 2007-06-05 | 2007-11-07 | 北京艺信堂医药研究所 | 一种治疗复发性口疮的中药制剂 |
-
2008
- 2008-12-09 CN CN2008102381267A patent/CN101422579B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1317328A (zh) * | 2000-04-13 | 2001-10-17 | 崔北双 | 一种口腔溃疡药 |
CN1857635A (zh) * | 2006-03-29 | 2006-11-08 | 王忠英 | 一种治疗口臭的漱口内服中药制备方法 |
CN1895585A (zh) * | 2006-06-28 | 2007-01-17 | 陈江 | 口气清新饮料 |
CN101066399A (zh) * | 2007-06-05 | 2007-11-07 | 北京艺信堂医药研究所 | 一种治疗复发性口疮的中药制剂 |
Non-Patent Citations (2)
Title |
---|
张杰等.中医药治疗复发性口疮研究进展.《河南中医学院学报》.2003,(第1期),85-86. * |
胡学刚.口疮辩治4则.《新中医》.1995,(第4期),14. * |
Also Published As
Publication number | Publication date |
---|---|
CN101422579A (zh) | 2009-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101422579B (zh) | 一种治疗口腔溃疡的中药制剂 | |
CN103417904B (zh) | 一种治疗慢性唇炎的中药组合物及其制备方法 | |
CN102579988B (zh) | 用于预防和治疗牙龈炎的中药、中草药牙粉及制备方法 | |
CN101934052B (zh) | 一种治疗面部黄褐斑的药物及其制备方法 | |
CN103520572A (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN102370878B (zh) | 治疗口舌生疮的中药口服制剂 | |
CN104524337A (zh) | 一种治疗口腔溃疡的中药 | |
CN103349693B (zh) | 一种治疗过敏性鼻炎的外用中药组合物 | |
CN103041256B (zh) | 一种治疗小儿反复呼吸道感染的中药制剂 | |
CN103055116A (zh) | 一种治疗痤疮的中药组合物 | |
CN104984316A (zh) | 用于治疗女性宫寒的药物 | |
CN104306766A (zh) | 防治放射性口腔黏膜炎的中药方剂及其制作方法 | |
CN104524287A (zh) | 一种治疗过敏性紫癜的中药组合物及其制备方法 | |
CN103041257B (zh) | 治疗小儿发热高烧呼吸道感染的中药制剂 | |
CN101264250B (zh) | 一种治疗口腔溃疡的中药组合物 | |
CN101239134B (zh) | 祛斑药物组合物 | |
CN103041255B (zh) | 治疗小儿咽喉肿痛呼吸道感染的中药制剂 | |
CN106177542A (zh) | 一种清暑解毒的中药组方及其制品 | |
CN104606600A (zh) | 一种治疗间质性肺病的中药组合物及其制备方法 | |
CN104208621A (zh) | 一种治疗麦粒肿的中药 | |
CN104740405B (zh) | 一种治疗过敏性紫癜性肾损害的中药制剂及制备方法 | |
CN103041258B (zh) | 治疗小儿呼吸道感染伴纳差不食的中药制剂 | |
CN103784720A (zh) | 一种降血糖尿糖的中药制剂 | |
CN103285116B (zh) | 一种用于治疗幼儿感冒的中药制剂 | |
CN102406913A (zh) | 一种治疗郁证的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110615 Termination date: 20111209 |